醫(yī)療特長：擅長狼瘡腎炎,、IgA腎病、腎病綜合征,、急性及慢性腎衰竭的診斷及治療,，熟練掌握腎活檢及腹膜透析技術(shù)
研究方向：1.腹膜透析相關(guān)性腹膜纖維化的發(fā)病機(jī)制；
2.狼瘡性腎炎新型治療藥物開發(fā)
主要教育和工作經(jīng)歷：2015年畢業(yè)于中山大學(xué)獲內(nèi)科學(xué)博士學(xué)位,，后長期于中山大學(xué)附屬第一醫(yī)院腎內(nèi)科工作
社會兼職：廣東省精準(zhǔn)醫(yī)學(xué)應(yīng)用學(xué)會腎臟病分會委員,，廣東省醫(yī)師協(xié)會腎臟內(nèi)科醫(yī)師分會青年組委員。
論著：1. Yu JW, Duan WJ, Huang XR, Meng XM, Yu XQ, Lan HY. MicroRNA-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis. Lab Invest, 2014. 94(9): p978-90.
2. Cai L, Yu JW, Yu J, Peng Y, Ullah H, Yi CY, Lin J, Yang X, Yu X. Prognostic value of inflammation-based prognostic scores on outcome in patients undergoing continuous ambulatory peritoneal dialysis. BMC Nephrol, 2018 Oct 26; 19(1):297.
3. Yu JW, Yu CL, Feng BY, Zhan XJ, Luo N, Yu XQ, Zhou Q. Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs. BMC Nephrol. 2019 Aug 27;20(1):336.
4. Zhang PH, Yu CL, Yu JW, Li ZJ, Lan HY, Zhou Q. Arid2-IR promotes NF-κB-mediated renal inflammation by targeting NLRC5 transcription, Cellular and Molecular Life Sciences, 2020, 78(5): 2387-2404.
5. Yu JW, Xie DL, Huang NY, Zhou Q. Circular RNAs as Novel Diagnostic Biomarkers and Therapeutic Targets in Kidney Disease, Frontiers in Medicine, 2021, 8: 714958.
